期刊文献+

miR-378靶向胰岛素样生长因子1类受体抑制肝癌细胞生长 被引量:7

miR-378 suppresses HBV-related hepatocellular carcinoma tumor growth by directly targeting the insulin- like growth factor 1 receptor
原文传递
导出
摘要 目的探讨miR-378对肝癌细胞生长增殖的影响及其机制。方法用miR-378过表达慢病毒感染肝癌细胞株HepG2和稳定表达HBV的肝癌细胞株HepG2.2.15,采用四甲基偶氮唑盐和克隆形成实验研究其在肝癌发生和发展中的作用。生物信息学方法预测miR-378的靶基因,荧光素酶报告实验验证靶基因,并用实时定量PCR方法和Westernblot方法研究上调miR-378表达对其靶基因表达的影响,分析miR-378在肝癌中作用的机制。采用SPSS13.0软件进行统计分析,两组间比较采用t检验。结果与空载体感染组比较,miR-378过表达慢病毒感染组肝癌细胞的增殖活性降低和克隆形成减少,差异有统计学意义沪〈0.01或尸〈0.05)。用生物信息学方法预测胰岛素样生长因子1类受体(IGF1R)为miR-378的靶基因,荧光素酶报告实验结果显示,与对照组比,miR-378与IGF1R3’-UTR共转染组荧光酶活性下降了41.8%,差异有统计学意义(P〈0.01)。上调肝癌细胞中miR-378表达后,IGF1RmRNA表达与对照组差异无统计学意义垆〉0.05),而IGFlR蛋白表达水平显著降低垆〈0.01)。结论miR-378可抑制肝癌细胞的增殖和克隆形成,起抑癌基因的作用,其作用是通过抑制其下游靶基因IGF1R发挥的。HBV导致的miR-378下调表达可能是HBV相关性肝癌发生和发展的分子机制之一。 Objective To investigate the impact and mechanism of microRNA (miR)-378 on hepatocellular carcinoma (HCC) cell growth. Methods The human hepatoma cell line HepG2 and its derivative HepG2.2.15 (stably expressing hepatitis B virus (HBV)) were transduced with lentiviruses expressing miR-378 or non-expressing controls (nc-Lv). Effects on cell proliferation were assessed by the MTT assay and on colony-formation efficiency by clonogenic assay. Targets of miR-378 were predicted by bioinformatic analysis and validated by luciferase reporter assay in the human embryonic kidney cell line HEK293. Real-time polymerase chain reaction and western blotting were used to monitor expression of the endogenous targets in miR-378- overexpressing HepG2 and HepG2.2.15 cells. Results The HepG2 and HepG2.2.15 cells transduced with lentivirus expressing miR-378 showed significantly lower cell proliferation and colony formation than the control cells transduced with nc-Lv (P 〈 0.01 and P 〈 0.05, respectively). The insulin-like growth factor 1 receptor (IGF1R) was predicted as a potential target of miR-378, and luciferase reporter activity of IGF1R was significantly decreased in the HEK293cells co-transfected with miR-378 (by 41.8% vs. the control cells, P 〈 0.01). Moreover, the miRNA-378- mediated effect was narrowed down to the 3'-untranslated region (UTR) of IGF1R. The miRNA-378- mediated reduction of IGF1R specifically involved its protein expression (P 〈 0.01) and not its mRNA expression (P 〉 0.05). Conclusion miR-378 may suppress growth characteristics ofHBV-related HCC by directly targeting the IGF1R 3'-UTR and inhibiting its protein expression.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2013年第8期609-613,共5页 Chinese Journal of Hepatology
基金 基金项目:无锡市医院管理中心项目(YGZ1016,YGZ1106)
关键词 肝细胞 肝炎病毒 乙型 细胞增殖 胰岛素样生长因子1类受体 miR-378 Carcinoma, hepatocellular Hepatitis B virus Cell proliferation Insulin-like growth factor 1 receptor miR-378
  • 相关文献

参考文献1

共引文献37

同被引文献62

  • 1茹松伟,申卫红,杨鹏程,赵屹,邵启祥.microRNA靶基因预测算法研究概况及发展趋势[J].生命科学,2007,19(5):562-567. 被引量:17
  • 2Hsu PW C, Lin L Z, Hsu S D, et al. ViTa: prediction of host microRNAs targets on viruses [J]. Nucleic Acids Research, 2007, 35 (Database issue): D381-D385.
  • 3Arbuthnot P. MicroRNA-like antivirals [J]. Biochimica Et BiophysicaActa-Gene Regulatory Mechanisms, 2011, 1809(11-12): 746-755.
  • 4Bivalkar-Mehla S, Vakharia J, Mehla R, et al. Viral RNA silencing suppressors (RSS): Novel strategy of viruses to ablate the host RNA interference (RNAi) defense system [J]. Virus Research, 2011, 155 ( 1 ): 1-9.
  • 5Gottwein E. Roles of MicroRNAs in the Life Cycles of Mammalian Viruses[M]. In: Cullen BR, ed. Intrinsic Immunity, 2013:201-227.
  • 6Revill P, Locarnini S. The clinical virology of hepatitis B [J]. Future Virology, 2006, 1(3): 349-360.
  • 7Qiu L, Fan H, Jin W, et al. miR-122-induced down-regulation of riO-1 negatively affects miR-122-mediated suppression of HBV [J]. Biochemical and Biophysical Research Communications, 2010, 398 (4): 771-777.
  • 8Zhang G L, Li Y X, Zheng S Q, et al. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210 [J]. Antiviral Res, 2010, 88(2): 169-175.
  • 9Hu W, Wang X, Ding X, et al. MicroRNA-141 Represses HBV Replication by Targeting PPARA[J]. Plos One, 2012, 7(3):e34165.
  • 10Kohno T, Tsuge M, Murakami E, et al. Human microRNA hsa-miR- 1231 suppresses hepatitis B virus replication by targeting core mRNA [J]. J Viral Hepat, 2014, 21(9): e89-97.

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部